For: | Gao YJ, Xin Y, Zhang JJ, Zhou J. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma. World J Gastroenterol 2008; 14(32): 5000-5007 [PMID: 18763281 DOI: 10.3748/wjg.14.5000] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i32/5000.htm |
Number | Citing Articles |
1 |
Sheru Sanbhnani, Foong May Yeong. CHFR: a key checkpoint component implicated in a wide range of cancers. Cellular and Molecular Life Sciences 2012; 69(10): 1669 doi: 10.1007/s00018-011-0892-2
|
2 |
Ya-Chao Hou, Jing-Yu Deng. Role of E3 ubiquitin ligases in gastric cancer. World Journal of Gastroenterology 2015; 21(3): 786-793 doi: 10.3748/wjg.v21.i3.786
|
3 |
Yazhuo Li, Yunsheng Yang, Youyong Lu, James G. Herman, Malcolm V. Brock, Po Zhao, Mingzhou Guo. Predictive value of CHFR and MLH1 methylation in human gastric cancer. Gastric Cancer 2015; 18(2): 280 doi: 10.1007/s10120-014-0370-2
|
4 |
Chen Wang, Wenxia Ma, Rong Wei, Xiaoqin Zhang, Ningning Shen, Lifang Shang, Li E, Ying Wang, Lifang Gao, Xin Li, Bin Wang, Yaping Zhang, Aiping Du. Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget 2017; 8(65): 109732 doi: 10.18632/oncotarget.21962
|
5 |
Zubeyde Yalniz, Semra Demokan, Yusufhan Suoglu, Murat Ulusan, Nejat Dalay. Simultaneous Methylation Profiling of Tumor Suppressor Genes in Head and Neck Cancer. DNA and Cell Biology 2011; 30(1): 17 doi: 10.1089/dna.2010.1090
|
6 |
Shi-Lian Hu, Da-Bing Huang, Yu-Bei Sun, Lei Wu, Wei-Ping Xu, Shi Yin, Jiong Chen, Xiao-Dong Jiang, Gan Shen. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. Medical Oncology 2011; 28(2): 447 doi: 10.1007/s12032-010-9467-6
|
7 |
Huizhen Wang, Yida Lu, Mingliang Wang, Youliang Wu, Xiaodong Wang, Yongxiang Li. Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance. Journal of Molecular Medicine 2021; 99(2): 193 doi: 10.1007/s00109-020-02015-5
|
8 |
Yanan Zheng, Lu Chen, Jianfang Li, Beiqin Yu, Liping Su, Xuehua Chen, Yingyan Yu, Min Yan, Bingya Liu, Zhenggang Zhu. Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis. Clinical Biochemistry 2011; 44(17-18): 1405 doi: 10.1016/j.clinbiochem.2011.09.006
|
9 |
Yong Ding, Hai-Feng Lian, Yaowu Du. Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis. Oncotarget 2018; 9(11): 10083 doi: 10.18632/oncotarget.23394
|
10 |
Shi-Lian Hu, Xiang-Yong Kong, Zhao-Dong Cheng, Yu-Bei Sun, Gan Shen, Wei-Ping Xu, Lei Wu, Xiu-Cai Xu, Xiao-Dong Jiang, Da-Bing Huang. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Tumori Journal 2010; 96(5): 726 doi: 10.1177/030089161009600515
|